Pharmacist Compliance Written 1 credit hour

Pharmacy professionals play a vital role in reducing opioid-related morbidity and mortality by identifying patients at risk for opioid-induced respiratory depression. This course provides an overview of current recommendations for naloxone co-prescribing, addressing common misconceptions, patient concerns, and professional responsibilities in opioid safety. You will gain the knowledge and confidence to educate patients, promote harm reduction, and effectively dispense this life-saving medication in pharmacy practice.

Learning Objectives

Upon successful completion of this application-based course, participants should be able to:
1. Explain the importance of naloxone access in reducing opioid-related morbidity and mortality.
2. Recommend naloxone for patients at risk of opioid-induced respiratory depression based on established risk factors.
3. Compare the characteristics, administration routes, and appropriate use of available naloxone formulations.
4. Discuss common clinician, patient, and caregiver concerns related to naloxone use and accessibility.
5. Incorporate key components of naloxone education when counseling patients and caregivers.

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Kashelle Lockman and Joshua Kinsey has no relevant financial relationships with ineligible companies to disclose.

Kashelle Lockman, PharmD, MA

Clinical Associate Professor
University of Iowa

Disclosures:

Kashelle Lockman and Joshua Kinsey has no relevant financial relationships with ineligible companies to disclose.

Course Details